Fulcrum Therapeutics (FULC) Other Accumulated Expenses (2018 - 2026)
Fulcrum Therapeutics (FULC) reported Other Accumulated Expenses of $174,000 for Q2 2026, up 0.6% from $173,000 a year earlier but down 43.5% from the prior quarter.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Fulcrum Therapeutics posted Other Accumulated Expenses of $258,000, down 44.3% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of 42.4% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $463,000 in FY2024 (+16.9%), $396,000 in FY2023 (+277.1%), $105,000 in FY2022 (+41.9%) and $74,000 in FY2021 (+68.2%).
- Five-year quarterly Other Accumulated Expenses spans a low of $9,000 in Q1 2023 and a high of $463,000 in Q4 2024.
- Year over year, Other Accumulated Expenses gained in four of the last eight quarters, with an average decline of 9.5%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2023 (growth of 960.0%); the low point was Q1 2023 (a decline of 93.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $308,000 (Q1 2026), $258,000 (Q4 2025) and $236,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Fulcrum Therapeutics | 281.49 Mn | 281.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 174,000.00 |
| Mar 31, 2026 | 308,000.00 |
| Dec 31, 2025 | 258,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 173,000.00 |
| Mar 31, 2025 | 441,000.00 |
| Dec 31, 2024 | 463,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 306,000.00 |
| Mar 31, 2024 | 385,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Sep 30, 2023 | 265,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 57,000.00 |
API Access
Fulcrum Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();